Phase-3 safety data from studies comparing galcanezumab and placebo in patients with episodic and chronic migraine

EUROPEAN JOURNAL OF NEUROLOGY(2018)

引用 5|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要